G43

CAS No. 690693-02-8

G43( —— )

Catalog No. M37004 CAS No. 690693-02-8

G43 is a potent and selective glucosyltransferase inhibitor that inhibits GtfB and GtfC with Kd values of 3.7 μM and 46.9 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 174 In Stock
5MG 172 In Stock
10MG 254 In Stock
25MG 392 In Stock
50MG 531 In Stock
100MG 710 In Stock
200MG 958 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    G43
  • Note
    Research use only, not for human use.
  • Brief Description
    G43 is a potent and selective glucosyltransferase inhibitor that inhibits GtfB and GtfC with Kd values of 3.7 μM and 46.9 nM, respectively.
  • Description
    G43 is a potent, selective glucosyltransferaseinhibitor, with the Kd of 3.7μM and 46.9 nM for GtfB and GtfC, respectively. G43 has antibacterial to S. mutans in vitro and in vivo, and can be used for dental caries study.
  • In Vitro
    RT-PCR Cell Line:S. mutans. UA159 cells Concentration:3.125, 6.25, 12, 25 μM Incubation Time:24 h Result:Showed no significant difference on expression of gtfs (gtfB, gtfC and gtfD).
  • In Vivo
    Animal Model:The rat model of dental caries infected with S. mutans UA159 Dosage:100?μM twice daily for 4 weeks Administration:Topically administration Result:Reduced the buccal, sulcal, and proximal surface caries scores, but did not lose weight over the course of the study.
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Transferase | Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    690693-02-8
  • Formula Weight
    341.34
  • Molecular Formula
    C16H11N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC1=C(C(N)=O)C=CC=C1)(=O)C2=CC=3C(S2)=CC=C(N(=O)=O)C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang Q, et al. Structure-Based Discovery of Small Molecule Inhibitors of Cariogenic Virulence. Sci Rep. 2017;7(1):5974.?
molnova catalog
related products
  • Eliglustat

    Eliglustat (Tartrate) inhibits?glucosylceramide synthase(GCS),thus reducing the load of glucosylceramide influx into the lysosome.

  • FGTI-2734

    FGTI-2734 can prevent membrane localization of KRAS, hence solving KRAS resistance problem and thwarting mutant KRAS patient-derived pancreatic tumors.?

  • Pradigastat

    Pradigastat (LCQ-908) is an orally active, potent and selective diacylglycerol acyltransferase 1 (DGAT1) inhibitor for the treatment of constipation, which may be used in the study of obesity and diabetes.